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ABSTRACT – The uveodermatological syndrome, an auto-immune disorder having ophthalmic and
dermal signs, has been described frequently in Akita dogs, rarely in other purebred dogs but none
description of this syndrome in mixed breed dogs has been reported. In this paper, we describe the
syndrome in a Cocker-Poodle mixed breed dog.
Key words: dermal depigmentation, uveitis, uveodermatological syndrome (UDS), Vogt-Koyanagi-
Harada Syndrome (VKHS).
RESUMO – A síndrome uveodermatológica, um distúrbio auto-imune que apresenta sinais oculares
e cutâneos, tem sido descrita freqüentemente em cães da raça Akita, raramente, em outras raças e
não há relato em cães mestiços. Neste artigo, descreve-se a síndrome em um cão mestiço Cocker
com Poodle.
Palavras chave: despigmentação cutânea, uveíte, síndrome uveodermatológica (SUD), síndrome
Vogt-Koyanagi-Harada (SVKH).
Introduction
The Vogt-Koyanagi-Harada (VKH) syndrome
is a well known disease in human beings. It was
first described by Vogt in 1906, by Koyanagi in
1929 and by Harada in 1926. The cause of this
syndrome in human beings has been a mystery,
but since 1969 there has been substantial
evidence that it is an immune-mediated disease
in which melanocytes are the target cells
(MORGAN, 1989).
In man, the VKH syndrome has four
recognized phases: (1) prodromal,
characterized by neurologic and auditory
manifestations; (2) acute uveitis, characterized
by diffuse choroiditis, which may manifest as
exudative retinal detachments and papillitis, with
or without clinical signs of intraocular
inflammation; (3) chronic, characterized by the
variable development of depigmentation of the
fundus (sunset glow fundus) and limbus
(Sugiura sign), as well as poliosis, vitiligo and
alopecia; and (4) chronic-recurrent, which may
interrupt the chronic phase with iridociclitis, which
can be recurrent, chronic or both (READ et al.,
2001a).
The first report of dogs having a similar
disorder to the VKH syndrome of human beings
was made in Japan in 1977 in Akita dogs
(ASAKURA et al., 1977). The Akita has been
notably the most affected dog breed (ASAKURA
et al., 1977; HASEGAWA, 1985;
ROMATOWSKI, 1985; BEDFORD, 1986;
COTTRELL; BARNETT, 1987; FURLONG et al.,
1989; LINDLEY et al., 1990; BARROS et al.,
1991; MURPHY et al., 1991). There have been
reports of the occurrence of this disease in other
breeds as Samoyed, Irish Setter (BUSSANICH
et al., 1982), Golden Retriever, Old English
Sheepdog, Saint Bernard, Shetland Sheepdog
(KERN et al., 1985), Australian Shepherd
(FABRIÈS, 1984; KERN et al., 1985), Siberian
Husky (FABRIÈS, 1984; KERN et al., 1985;
TACHIKAWA et al., 1990; VERCELLI;
TARAGLIO, 1990; GUAGUERE-LUCAS et al.,
1995; DENEROLLE et al., 2000), Chow Chow
(MORGAN, 1989; WARMOES, 1999),
Dachshund (HERRERA and DUCHENE, 1998)
and Fox Terrier (SLINCKX; FONTAINE, 1999).
In dogs, the disease lacks the systemic
component, and is called uveodermatological
syndrome (UDS). The ocular signs are usually
the first abnormality noticed, which include
bilateral anterior and posterior uveitis to severe
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panuveitis. Retinal detachment, optic neuritis,
or changes in choroidal pigments may also be
present. The dermatological signs include
depigmentation of the eyelids, lips, nose and,
less commonly of the scrotum, vulva, footpads,
and anus. Neurological signs are rare, described
only twice, in one Akita (COTTRELL and
BARNETT, 1987) and in one Siberian Husky
(DENEROLLE et al., 2000), but the suggestion
of the neurological disease was made based
only in behavioral changes, additional
neurological evaluation was not performed.
Corticosteroids have been usually the treatment
of choice for human beings and dogs. Other
immunosupressive drugs can be associated
when necessary.
This syndrome is not a life threatening
disease, however the prognosis for vision is
poor, because severe complications often lead
to visual loss.
Case Report
A 21/
2
 -year-old male mixed breed dog (English
Cocker Spaniel x Poodle) was referred with a history
of eye redness in the last 5 months. The owner
reported visual impairment and the use of several
systemic and topical medications with no success.
FIGURA 1 – A) CORNEAL OPACITY AND NEW VESSELS OF THE CORNEA OF RIGHT AND LEFT EYES.
B)  DERMAL DEPIGMENTATION OF THE NASAL PLANUM AND SCROTUM WITH
EROSIONS AND CRUSTS.
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The first ophthalmic examination revealed
mild enlargement of the eyes, moderate mucous
discharge, moderate to severe conjunctival
hyperemia; opacity and vessels at the corneal
surface. In the anterior chamber, there was an
intense flare and rubeosis iridis. The pupillary
light reflexes in both eyes were absent. The lens
were cataractous, hence the ocular fundi could
not be evaluated (FIGURA 1A). The IOP was
10 mmHg (TONOPEN) in both eyes. The dog
had depigmentation of the lips, nasal planum,
and scrotum (FIGURA 1B). Complete blood
count has been performed. The treatment was
prednisone 1mg/kg once a day; dexamethasone
+ neomycin + polymyxin four times a day; 1%
atropine ophthalmic solution - twice a day for
three days, and, once a day afterwards after one
week, at the first examination, hyphema
developed in the anterior chamber. The
laboratory analysis (complete blood count,
biochemistry) was normal, so a presumptive
diagnosis of UDS was made. Skin samples were
taken for hystological examination. One month
later, the eyes were smaller, there was no
conjunctival hyperemia, and the hyphema had
disapeared, thereafter the medication was
tapered and then discontinued. One month after
the medication has been discontinued, the
owner claimed that the dog eyes became red
again, and at the ophthalmic examination, it has
been observed that the ophthalmic signs had
gotten worse. The medication (oral prednisone
and topical dexamethasone + neomycin +
polymyxin) was introduced again. Meanwhile,
the result of the histological analysis had shown
features compatible with the UDS.
Discussion
The VKH syndrome (VKHS) in human beings
is considered a chronic, bilateral, granulomatous
ocular and multisystemic inflammatory condition
of unknown cause (READ et al., 2001a). It
affects primarily Asians, Latinos, Native
Americans or Asian Indians. Women appear to
be affected more commonly than men. VKH
disease may occur at all ages, including
childhood (READ et al., 2000). Experimental
data continue to support an autoimmune
etiology for VKH disease, directed most probably
against  an melanocyte antigenic component,
possibly tyrosinase or tyrosinase-related protein
(YAMAKI et al., 2000), an identified 75kDa
protein obtained from cultured human melanous
cells (G-361) (KONDO et al., 1994) and the S-
100 protein (GLODDEK et al., 1999). There are
some evidence about the involvement of the
Epstein-Barr virus in the pathogenesis of the
VKHS (MINODA et al., 1999). In some cases, it
is thought that the trigger is a cutaneous injury
(RATHIMAN et al., 1999). There is likely a
genetic predisposition, since specific HLA types
have been associated with the disease (READ
et al., 2001a).
There are no specific diagnostic tests for the
VKH disease. The diagnosis is therefore based
on a combination of suggestive clinical and
ancillary test findings when other uveitic conditions
have been excluded (READ et al., 2001b).
The features of the VKH syndrome may be
shared by multiple other entities, such as
sarcoidosis, sympathetic ophthalmia, syphilitic
uveitis, tuberculosis uveitis, Lyme disease,
posterior scleritis, intraocular lymphoma, central
serous choroidopathy and uveal effusion
syndrome (READ et al., 2001a). The most
affected breed has been the Akita, althoug other
breeds can be affected.
There is no sexual predisposition
(HASEGAWA, 1985; MORGAN, 1989;
BARROS et al., 1991) and the age of onset is
7-72 months (BARROS et al., 1991).
As in human beings, the cause of the UDS in
dogs remains unknown. Routine parameters are
normal, and immune-function tests are usually
nondiagnostic (MORGAN, 1989). Hereditary
condition is suggested (HASEGAWA, 1985;
COTTRELL; BARNETT, 1987)
Histologically, canine ocular lesions closely
resemble those of humans. The uveal tract is
diffusely infiltrated with lymphocytes, plasma
cells, epithelioid cells and pigment-ladden cells
(BUSSANICH et al., 1982; KERN et al., 1985;
MORGAN, 1989; LINDLEY et al., 1990). In the
inflammed areas, electron microscopy has
demonstrated numerous macrophages
containing ingested melanosomes
(BUSSANICH et al., 1982).
Depigmentation of the hair and skin usually
follows the onset of ocular signs. Dermal
depigmentation often involves the eyelids, nasal
planum, lips, scrotum, and footpads (MORGAN,
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1989). Few cases have involved generalized
vitiligo (CAMPBELL et al., 1986; HERRERA and
DUCHENE, 1998).
Dermatohistopathologic findings include  an
interface dermatitis composed of large
histiocytic cells, small mononuclear cells, and
plasma cells. Other manifestations are irregular
epidermal hyperplasia with hyperkeratosis and
pigmentary incontinence with decreased
numbers of epidermal melanocytes (BOLDY et
al., 1989). There is one report about the
association of anti-retinal antibodies with UDS
(MURPHY et al., 1991).
The general guidelines in the therapy
involve 1 to 2 mg/kg per day of oral
prednisone (MORGAN, 1989). By analogy
with human experience in VKH disease,
systemic corticosteroids should be continued
at relatively high doses for at least two or three
months, and perhaps for as long as six
months (ROMATOWSKI, 1985).
Unfortunately, the prognosis for vision is often
poor.
The macroscopic and microscopic lesions in
the case presented in this paper were consistent
with the uveodermatological syndrome
described in dogs.
The veterinary practitioner should maintain a
suspicion for this uveodermatological syndrome
not only in the Akita dog, but in any dog
displaying signals that remind those of this
particular disease.
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